Aziz Sura, Wik Elisabeth, Knutsvik Gøril, Klingen Tor Audun, Chen Ying, Davidsen Benedicte, Aas Hans, Aas Turid, Akslen Lars A
Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, Section for Pathology, University of Bergen, Bergen, Norway.
Department of Pathology, Haukeland University Hospital, Bergen, Norway.
PLoS One. 2017 Feb 15;12(2):e0171853. doi: 10.1371/journal.pone.0171853. eCollection 2017.
Presence of lymph node (LN) metastasis is a strong prognostic factor in breast cancer, whereas the importance of extra-nodal extension and other nodal tumor features have not yet been fully recognized. Here, we examined microscopic features of lymph node metastases and their prognostic value in a population-based cohort of node positive breast cancer (n = 218), as part of the prospective Norwegian Breast Cancer Screening Program NBCSP (1996-2009). Sections were reviewed for the largest metastatic tumor diameter (TD-MET), nodal afferent and efferent vascular invasion (AVI and EVI), extra-nodal extension (ENE), number of ENE foci, as well as circumferential (CD-ENE) and perpendicular (PD-ENE) diameter of extra-nodal growth. Number of positive lymph nodes, EVI, and PD-ENE were significantly increased with larger primary tumor (PT) diameter. Univariate survival analysis showed that several features of nodal metastases were associated with disease-free (DFS) or breast cancer specific survival (BCSS). Multivariate analysis demonstrated an independent prognostic value of PD-ENE (with 3 mm as cut-off value) in predicting DFS and BCSS, along with number of positive nodes and histologic grade of the primary tumor (for DFS: P = 0.01, P = 0.02, P = 0.01, respectively; for BCSS: P = 0.02, P = 0.008, P = 0.02, respectively). To conclude, the extent of ENE by its perpendicular diameter was independently prognostic and should be considered in line with nodal tumor burden in treatment decisions of node positive breast cancer.
淋巴结(LN)转移的存在是乳腺癌的一个强有力的预后因素,而结外扩展和其他淋巴结肿瘤特征的重要性尚未得到充分认识。在此,作为前瞻性挪威乳腺癌筛查项目NBCSP(1996 - 2009年)的一部分,我们在一个基于人群的淋巴结阳性乳腺癌队列(n = 218)中研究了淋巴结转移的微观特征及其预后价值。对切片进行了检查,以确定最大转移瘤直径(TD - MET)、淋巴结输入和输出血管侵犯(AVI和EVI)、结外扩展(ENE)、ENE病灶数量,以及结外生长的圆周直径(CD - ENE)和垂直直径(PD - ENE)。阳性淋巴结数量、EVI和PD - ENE随着原发肿瘤(PT)直径增大而显著增加。单因素生存分析表明,淋巴结转移的几个特征与无病生存(DFS)或乳腺癌特异性生存(BCSS)相关。多因素分析表明,PD - ENE(以3 mm为临界值)在预测DFS和BCSS方面具有独立的预后价值,同时还有阳性淋巴结数量和原发肿瘤的组织学分级(对于DFS:P分别为0.01、0.02、0.01;对于BCSS:P分别为0.02、0.008、0.02)。总之,ENE垂直直径的范围具有独立的预后意义,在淋巴结阳性乳腺癌的治疗决策中应与淋巴结肿瘤负荷一并考虑。